CSL Behring is at the forefront of working closely with academia in areas of the world that are important to its global business to help bring ideas for new and innovative therapies that meet unmet patient needs.
As part of that effort, CSL Behring has located its Global Hub for Research and Translational Medicine on the campus of the University of Melbourne as part of a major expansion of the Bio21 Institute. About 150 CSL Behring scientists are working on-site at the institute today. The heart of the expansion is the newly opened Nancy Millis Building (above).
“Bio21 is a world-class facility and a strong example of CSL Behring’s growing R&D footprint,” said, Mike Wilson, CSL Behring’s Vice President of Research at Bio21. “The science we are advancing and relationships we are forging may lead to innovations that’ll help patients with rare and serious diseases lead full lives.”
Here’s an inside look at CSL Behring’s on-site operations at Bio21.
The biotechnology leader’s scientists have been working on-site at Bio21 since 2007. The partnership between CSL Behring and the University of Melbourne gives the company’s scientists access to leading-edge equipment and a highly collaborative work environment.
CSL Behring labs at the Bio21 Institute are equipped to handle a host of areas of research focus, including translational medicine, analytical and protein biochemistry, molecular biology and cell line development.
The Nancy Millis Building is named for one of the first women to be appointed a professor at the University of Melbourne. Millis introduced fermentation technologies to Australia. The building holds a 5 Star Green Rating from the Green Building Council of Australia. It was built using an innovative technique and environmentally friendly technique that requires less concrete than traditional structures.
The Bio21 Institute is located in Melbourne’s Parkville knowledge precinct, an area that also hosts CSL’s headquarters. The location enables the company to access important platform technologies as well as recruit highly skilled scientists.
